News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Orlinger Klaus
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2022 |
4
| Orlinger Klaus (Chief Scientific Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 48,350 options to buy
@ $1.66, valued at
$80.3k
|
|
02/01/2022 |
4
| Orlinger Klaus (Executive VP, Research) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 9,188 shares
@ $3, valued at
$27.6k
Granted 12,654 options to buy
@ $1.5, valued at
$19k
|
|
04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2020 |
4
| Orlinger Klaus (EVP, Research) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 30,000 options to buy
@ $8.03, valued at
$240.9k
|
|
01/21/2020 |
4
| Orlinger Klaus (Sr. VP, Research) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Sold 1,711 shares
@ $11.5612, valued at
$19.8k
Sold 6,789 shares
@ $12.0182, valued at
$81.6k
Exercised 1,140 options to buy
@ $0.1, valued at
$114 Exercised 571 options to buy
@ $0.1, valued at
$57.1 Exercised 6,789 options to buy
@ $0.1, valued at
$678.9 |
|
01/16/2020 |
4
| Orlinger Klaus (Sr. VP, Research) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Sold 8,500 shares
@ $11.3003, valued at
$96.1k
Exercised 7,358 options to buy
@ $0.1, valued at
$735.8 Exercised 1,142 options to buy
@ $0.1, valued at
$114.2 |
|
04/24/2019 |
4
| Orlinger Klaus (Sr. VP, Research) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 42,784 options to buy
@ $14, valued at
$599k
|
|
04/17/2019 |
3
| Orlinger Klaus (Sr. VP, Research) has filed a Form 3 on HOOKIPA Pharma Inc. |
|
|